6550--Immunology ANA PREP TESTING

This document is a solicitation worksheet and pricing template for a federal procurement contract. It is designed for prospective vendors to submit pricing for Bio-Rad brand name or equivalent medical laboratory reagents, consumables, and testing equipment. The procurement covers 27 Line Items (CLINs) for autoimmune and diagnostic testing, specifically targeting ANA Screen, dsDNA, Chromatin DNP, Ribosomal P, SS-A, SS-B, Sm, Sm/RNP, RNP, Scl-70, Jo-1, Centromere-B, and Anti-CCP. Additionally, the list includes necessary laboratory consumables and maintenance supplies such as reaction vessels, sodium hydroxide, instrument sheath fluid, calibrator sets, detector calibration and clean packs, probe cleaning solutions, control sets, and reagent packs. The worksheet provides columns for vendors to enter their company details, SAM Unique Entity Identifier (UEI), proposed brand name or equivalent alternatives (including nomenclature, part numbers, and matching salient characteristics), quantities, unit prices, and extended totals. The contract period indicated for the pricing schedule is one year.

This Statement of Work (SOW) outlines the requirements for providing ANA (antinuclear antibody) reagents and supplies to the VA Greater Los Angeles Healthcare System (VAGLAHS). As a primary reference laboratory for VISN 22, the immunology department at VAGLAHS requires validated, proprietary reagents and supplies specifically compatible with their existing BioRad BioPlex instrumentation to maintain testing efficiency and reduce send-out costs. To support ongoing testing volumes, the contractor will provide these materials under an annual purchase order. While normal operating hours are Monday through Friday from 7:30 am to 5:00 pm (excluding federal holidays), the laboratory operates 24/7, and any off-hour deliveries or coordination must be approved by the Program Manager. Additionally, the contractor must comply with strict federal and VA security guidelines. This includes adhering to information security regulations, such as FISMA and NIST standards, to protect government data behind approved firewalls. Contractor personnel requiring access to VA computer systems must undergo background investigations and receive favorable adjudication from the VA Security and Investigations Center.

This Request for Information (RFI) and Sources Sought notice, reference number 36C26226Q1122, is issued by the Department of Veterans Affairs (VA), VISN 22 Network Contracting Office. The government is seeking potential qualified sources, particularly small businesses (such as SDVOSB, VOSB, Hubzone, and WOSB) under NAICS code 325413, to provide medical reagents for the VA Los Angeles Healthcare System. The purpose of this notice is market research and planning to determine appropriate acquisition strategies; it does not constitute a formal solicitation. Under the "Brand Name or Equal" clause (FAR 52.211-6), interested vendors must demonstrate that any proposed equivalent products meet all salient characteristics of the requested items. Additionally, the VA requires that all participants be authorized resellers, distributors, or dealers of the Original Equipment Manufacturer (OEM), as remanufactured or gray market supplies are strictly prohibited. Interested parties are requested to submit company details, business size status, federal contract vehicle information (e.g., FSS GSA, NASA SEWP, or NAC), product capabilities, and unofficial planning pricing. Responses must be submitted via email to Carlos.Magana@va.gov no later than July 17, 2026, at 9:00 AM PST.

This Sources Sought Notice (Solicitation Number 36C26226Q1122) is issued by the Department of Veterans Affairs, Network Contracting Office 22, to identify potential sources for Immunology ANA Prep Testing. The required services and products will support the VA Greater Los Angeles Healthcare System located in Los Angeles, California. The procurement is classified under NAICS code 325413 (In Vitro Diagnostic Substance Manufacturing) and Product Service Code 6550 (Chemical Analysis Instruments and Clinical Chemistry Reagents). Responses to this inquiry are due by July 17, 2026, at 9:00 AM Pacific Time. Interested parties are directed to review the attached Request for Information (RFI), Statement of Work (SOW), and Attachment A for complete technical specifications and submission details.